2017
DOI: 10.4103/ctm.ctm_67_16
|View full text |Cite
|
Sign up to set email alerts
|

Gastric metastases mimicking primary gastric cancer: A brief literature review

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2019
2019
2020
2020

Publication Types

Select...
3

Relationship

1
2

Authors

Journals

citations
Cited by 3 publications
(3 citation statements)
references
References 2 publications
0
3
0
Order By: Relevance
“…The suspicion of a metastasis from a lobular carcinoma of the breast is eliminated based on negativity for specific markers such mammaglobin, ER, PR, and GATA 3 [1, 3, 11, 12]. However, the poorly cohesive gastric carcinomas can express ER [1, 11, 12] and urothelial carcinoma can be diffusely positive for GCDFP-15 [1] and express nuclear GATA3 [1, 3]. CD138 can mark the breast lobular carcinoma but its expression is simultaneously seen in tumor and stroma cells [13].…”
Section: Discussionmentioning
confidence: 99%
“…The suspicion of a metastasis from a lobular carcinoma of the breast is eliminated based on negativity for specific markers such mammaglobin, ER, PR, and GATA 3 [1, 3, 11, 12]. However, the poorly cohesive gastric carcinomas can express ER [1, 11, 12] and urothelial carcinoma can be diffusely positive for GCDFP-15 [1] and express nuclear GATA3 [1, 3]. CD138 can mark the breast lobular carcinoma but its expression is simultaneously seen in tumor and stroma cells [13].…”
Section: Discussionmentioning
confidence: 99%
“…Patients present with a landscape of nonspecific symptoms such as anorexia, dysphagia, early satiety, postprandial bloating, epigastric pain, melena, nausea, and vomiting [ 12 , 24 , 29 ]. Aside from symptoms being nonspecific, they also mimic the side effects of chemotherapy or other medication, liver metastasis, and even hypercalcemia of malignancy [ 2 ].…”
Section: Reviewmentioning
confidence: 99%
“…This can further cause a delay in diagnosis or misdiagnosis of the disease. Clinically and endoscopically, it is almost impossible to differentiate primary GI tumors or non-Hodgkin lymphoma from metastatic disease [ 12 , 29 ].…”
Section: Reviewmentioning
confidence: 99%